Advanced Search
Your search returned 162 results
  • Feb 10, 2004

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...

  • Nov 17, 2001
    Spinal Products and Implantable Defibrillators, Two of Medtronic's Largest Product Lines, Led Second-Quarter Growth

    MINNEAPOLIS, Nov 17, 2004 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced quarterly net earnings of $535.7 million, or $0.44 per diluted share, an increase of 13 percent over the...

Show 5102550100 per page